SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-027049
Filing Date
2024-02-23
Accepted
2024-02-23 16:30:45
Documents
17
Period of Report
2023-03-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm242343d2_8k.htm   iXBRL 8-K 33334
2 EXHIBIT 16.1 tm242343d2_ex16-1.htm EX-16.1 4048
7 GRAPHIC tm242343d2_ex16-1img001.jpg GRAPHIC 6028
  Complete submission text file 0001104659-24-027049.txt   269829

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zura-20230329.xsd EX-101.SCH 3495
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zura-20230329_def.xml EX-101.DEF 26908
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20230329_lab.xml EX-101.LAB 36974
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20230329_pre.xml EX-101.PRE 25532
18 EXTRACTED XBRL INSTANCE DOCUMENT tm242343d2_8k_htm.xml XML 5500
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 24671709
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)